Furthermore, the results of Azoxymethane (AOM)/Dextran sulfate sodium (DSS)-induced animal models showed that pristimerin inhibits tumor growth mainly by inhibiting NF-κB activity in tumor tissues (41). The gene discussed is NFKB1; the disease is neoplasm.